The FDA's approval of Imfinzi plus chemotherapy and Keytruda plus chemotherapy deal with a major unmet wants.The current Meals and Drug Administration (FDA)...
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has launched an replace.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has introduced the primary profitable dosing in a Section...
CStone Prescription drugs (HK:2616) has launched an replace.
CStone Prescription drugs has granted unique promotion rights for AYVAKIT, a precision remedy for gastrointestinal stromal...
